Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: multi-agonist growth hormone signaling
Also known as: CJC/IPA/GHRP2
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
This blend combines a GHRH analog with two ghrelin-receptor agonists ipamorelin and GHRP-2. Combining two agents at the same receptor is not an established synergy and may increase adverse endocrine effects. No controlled fixed-blend study was found.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Component pharmacology and vendor/community market searches
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
The stated 15 mg total SKU was retained as market context but its component ratio was not independently standardized. The overlap between ipamorelin and GHRP-2 requires a human catalog decision.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention CJC-1295 No DAC + Ipamorelin + GHRP-2 or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.